Biogen Inc Q4 2020 Earnings Call Summary - Thomson StreetEvents

Biogen Inc Q4 2020 Earnings Call Summary

Biogen Inc Q4 2020 Earnings Call Summary - Thomson StreetEvents
Biogen Inc Q4 2020 Earnings Call Summary
Published Feb 03, 2021
19 pages (10972 words) — Published Feb 03, 2021
Price US$ 54.00  |  Buy this Report Now

About This Report

  
Abstract:

Edited Brief of BIIB.OQ earnings conference call or presentation 3-Feb-21 1:00pm GMT

  
Brief Excerpt:

...2. Committed to working with FDA as it completes review of aducanumab application. 3. Continues to stand behind Co.'s clinical data; believes Co.'s results support approval. B. 2020 Review: A year of uncertainties due to COVID-19 for both society at large and also for the industry. 1. 2. $13.4b in revenue, down 6% YoverY as Co. is experiencing the erosion of TECFIDERA revenue in US due to the impact of generic entry. 3. Non-GAAP EPS, $33.70, a slight increase versus full year 2019. C. Progress Against Strategic Priorities: Full year MS revenues, including OCREVUS royalties, were $8.7b, down 6% vs. prior year. 1. Excluding TECFIDERA in US, global MS revenue remained relatively stable for both 4Q and full year vs. 2019. a. 2. Despite challenges of launching a new product during COVID-19, saw strong improvement in trends for VUMERITY, which has become the Number 2 MS product and the Number 1 oral in terms of new prescriptions in US. Maintained leadership and executed well despite increased...

  
Report Type:

Brief

Source:
Thomson StreetEvents
Company:
Biogen Inc
Ticker
BIIB.OQ
Time
1:00pm GMT
Format:
PDF Adobe Acrobat
Buy Now

Biogen Inc Pre-Recorded Presentation of Cerebrospinal Fluid Biomarker Concordance with Amyloid PET in EMERGE and ENGAGE at AD/PD Transcript – 2021-03-10 – US$ 54.00 – Edited Transcript of BIIB.OQ corporate analyst meeting</ 10-Mar-21 11:45am GMT

Biogen Inc Live Discussion of Cerebrospinal Fluid Biomarker Concordance with Amyloid PET in EMERGE and ENGAGE at AD/PD Transcript – 2021-03-10 – US$ 54.00 – Edited Transcript of BIIB.OQ corporate analyst meeting</ 10-Mar-21 4:00pm GMT

Biogen Inc at Cowen Healthcare Conference (Virtual) Transcript – 2021-03-01 – US$ 54.00 – Edited Transcript of BIIB.OQ presentation 1-Mar-21 3:20pm GMT

Biogen Inc Aducanumab Webinar Update Transcript – 2021-02-23 – US$ 54.00 – Edited Transcript of BIIB.OQ conference call or presentation 23-Feb-21 7:00pm GMT

Biogen Inc Q4 2020 Earnings Call Transcript – 2021-02-03 – US$ 54.00 – Edited Transcript of BIIB.OQ earnings conference call or presentation 3-Feb-21 1:00pm GMT

Biogen Inc Corporate Call Summary – 2021-01-14 – US$ 54.00 – Edited Brief of BIIB.OQ conference call or presentation 14-Jan-21 2:00pm GMT

Biogen Inc Corporate Call Transcript – 2021-01-14 – US$ 54.00 – Edited Transcript of BIIB.OQ conference call or presentation 14-Jan-21 2:00pm GMT

Biogen Inc at JPMorgan Healthcare Conference (Virtual) Transcript – 2021-01-11 – US$ 54.00 – Edited Transcript of BIIB.OQ presentation 11-Jan-21 3:00pm GMT

Biogen Inc Conference Call to Discuss Collaboration with SAGE Therapeutics Inc Summary – 2020-11-30 – US$ 54.00 – Edited Brief of BIIB.OQ conference call or presentation 30-Nov-20 2:00pm GMT

Biogen Inc Conference Call to Discuss Collaboration with SAGE Therapeutics Inc Transcript – 2020-11-30 – US$ 54.00 – Edited Transcript of BIIB.OQ conference call or presentation 30-Nov-20 2:00pm GMT

More from Thomson StreetEvents

Thomson StreetEvents—Thomson StreetEvents is a leading provider of Web-based solutions for the investment community, offering services that transform the way companies communicate and meet disclosure requirements while assisting investors in managing and leveraging this information. Thomson StreetEvents service offers institutional investors a one-stop solution for managing corporate disclosure information by aggregating conference calls, webcasts, transcripts, call summaries, and other financial information into a time-saving, efficiency tool.
Purchase Thomson StreetEvents' Transcripts (verbatim reports) and Briefs (call summaries) of earnings, guidance, M&A and other corporate calls directly through Alacra. Discounted prices apply to reports produced over two weeks ago.

About the Author


Cite this Report

  
MLA:
Thomson StreetEvents. "Biogen Inc Q4 2020 Earnings Call Summary" Feb 03, 2021. Alacra Store. May 23, 2025. <http://www.alacrastore.com/thomson-streetevents-transcripts/Q4-2020-Biogen-Inc-Earnings-Call-B13591939>
  
APA:
Thomson StreetEvents. (2021). Biogen Inc Q4 2020 Earnings Call Summary Feb 03, 2021. New York, NY: Alacra Store. Retrieved May 23, 2025 from <http://www.alacrastore.com/thomson-streetevents-transcripts/Q4-2020-Biogen-Inc-Earnings-Call-B13591939>
  
US$ 54.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.